Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T49989 | Target Info | |||
Target Name | TGF-beta receptor type II (TGFBR2) | ||||
Synonyms | Transforminggrowth factor-beta receptor type II; Transforming growth factor-beta receptor type II; TbetaR-II; TGFR-2; TGF-beta type II receptor; TGF-beta receptor type-2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TGFBR2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Neuropilin-1 (NRP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VEGF165R; Vascular endothelial cell growth factor 165 receptor; Platelet-derived endothelial cell growth factor receptor; NRP; Membrane-bound; CD304 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Growth factors | [+] 2 Growth factors | + | |||
Interacting Target Name | Transforming growth factor beta 1 (TGFB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor beta-1 proprotein; Transforming growth factor beta-1; TGF-beta1; TGF-beta 1; TGFB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Reconstituted Complex | [5] | |||
Interacting Target Name | Transforming growth factor beta 3 (TGFB3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor beta-3 proprotein; Transforming growth factor beta-3; TGF-beta-3; Latency-associated peptide | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Affinity Capture-Western | [3] | |||
3 | Co-crystal Structure | [7] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Reconstituted Complex | [8] | |||
Kinases | [+] 3 Kinases | + | |||
Interacting Protein Name | Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AGM7; GRB1; IMD36; p85; p85.ALPHA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-MS | [10] | |||
3 | Affinity Capture-Western | [11] | |||
Interacting Protein Name | Phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MPPH; MPPH1; P85B; p85; p85.BETA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-MS | [10] | |||
3 | Affinity Capture-Western | [11] | |||
Interacting Target Name | TGF-beta receptor type I (TGFBR1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Type I TGFbeta receptor kinase; Transforming growth factor-beta receptor type I; TGFR-1; TGF-beta type I receptor; TGF-beta receptor type-1; TbetaR-I; TbetaRI; SKR4; Serine/threonine-protein kinase receptor R4; ALK-5; ALK5; Activin receptor-like kinase 5; Activin A receptor type II-like protein kinase of 53kD | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Yeast two hybrid | [13] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Target Name | Endoglin CD105 (ENG) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | END; CD105 antigen; CD105 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Biochemical Activity | [14] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem. 2010 Oct 8;285(41):31840-8. | ||||
REF 2 | Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis. 2011 Apr;32(4):613-21. | ||||
REF 3 | Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J. 2001 Feb 1;20(3):480-90. | ||||
REF 4 | Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 1993 Nov 19;75(4):671-80. | ||||
REF 5 | A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic ... J Biol Chem. 1993 Jun 15;268(17):12719-23. | ||||
REF 6 | Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999 Jan 8;274(2):584-94. | ||||
REF 7 | Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex. Nat Struct Biol. 2002 Mar;9(3):203-8. | ||||
REF 8 | Critical regulation of TGFbeta signaling by Hsp90. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9244-9. | ||||
REF 9 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 10 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 11 | TGF-beta 1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells. Am J Physiol. 1997 Dec;273(6 Pt 1):L1220-7. | ||||
REF 12 | Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells. J Biol Chem. 2009 Aug 14;284(33):22285-96. | ||||
REF 13 | TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol. 2001 Aug;3(8):708-14. | ||||
REF 14 | Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem. 2002 Aug 9;277(32):29197-209. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.